AzTrials
AzTrials

StrokeNCT07550270

Body Weight-Supported and Virtual Reality Gait Training in Stroke Patients

A study testing Virtual Reality-Assisted Gait Training, Backward Gait Training and Forward Gait Training in people with Stroke and Walking Impairment, run by Gaziler Physical Medicine and Rehabilitation Education and Research Hospital at 1 site in Turkey (Türkiye).

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

The aim of this study is to compare the effects of body weight-supported gait training that includes virtual reality-assisted dual-task applications with body weight-supported forward and backward gait training on functional capacity, gait parameters (such as step length, gait speed, and balance), cognitive functions… Read more about this study

Who is it for?
Ages 45 to 75 years
Conditions the study is for
Stroke, Walking Impairment, Balance
What is being tested?
Virtual Reality-Assisted Gait Training, Backward Gait Training and Forward Gait Training
Could I receive a placebo?
No, everyone receives an active treatment
How many people
30 participants
Where
1 siteTurkey (Türkiye)
Study dates
26 Mar 2026to Dec 2026
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 45 to 75 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Patients experiencing their first-ever stroke
  • Patients with a post-stroke duration of more than 2 weeks
  • Patients with plantar flexor muscle spasticity of the lower extremity less than grade 3 according to the Modified Ashworth Scale (MAS)
  • Patients with a Brunnstrom stage of the lower extremity greater than 2
  • Patients who are able to stand independently or under supervision for at least 2 minutes for standing assessments
  • Patients who are able to walk at least 10 meters independently or under supervision, with or without an assistive device, for walking assessments
Show all 9Show fewer
  • Patients with sufficient cognitive function to understand study instructions (Mini-Mental State Examination [MMSE] score > 23)
  • Patients with stable medical and psychological conditions
  • Patients who are willing to participate in the study

Who cannot join

  • Patients with bilateral hemispheric lesions
  • Patients with severe cardiovascular or musculoskeletal conditions that prevent walking (e.g., fixed ankle contracture)
  • Patients using a permanent urinary catheter, or those with pressure ulcers or urinary and/or fecal incontinence
  • Patients with unilateral neglect
  • Patients with neurological conditions other than stroke that may affect balance performance (e.g., Parkinson's disease, epilepsy, meningitis, cerebellar disorders, vertigo, dizziness, polyneuropathy) or musculoskeletal disorders (e.g., severe low back pain, knee disorders)
  • Patients with severe visual, hearing, or speech impairments

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Irem ERTORAN INAN, MD contact

03122912422

irem.ertoran@gmail.com

Turkey (Türkiye)1 site, 1 recruiting
  • Ankara, Çankaya, Türkiye (Türkiye), 06800 Gaziler Physical Medicine and Rehabilitation Training And Research Hospital

    Ankara, Çankaya, 06800

    Tuğba ATAN, 0 312 291 10 00, tubaatan@gmail.com

    Recruiting

Other trials in Turkey (Türkiye)

About this study

Official title: A Comparative Evaluation of the Effectiveness of Body Weight-Supported Forward and Backward Gait Training Versus Virtual Reality-Assisted Gait Training in Patients With Stroke

The aim of this study is to compare the effects of body weight-supported gait training that includes virtual reality-assisted dual-task applications with body weight-supported forward and backward gait training on functional capacity, gait parameters (such as step length, gait speed, and balance), cognitive functions and psychological status in patients with stroke. The findings of this study are expected to contribute to the development of more effective rehabilitation strategies for improving mobility in patients with stroke

Read the detailed description

Stroke is a leading cause of disability worldwide and often results in motor, balance, and cognitive impairments that negatively affect functional independence and quality of life. Walking limitations are among the most common consequences after stroke and represent a major barrier to community participation. Therefore, improving gait performance and functional mobility is a primary goal of stroke rehabilitation.

Body weight-supported gait training is widely used to improve walking ability in individuals with impaired balance and reduced motor function. In recent years, rehabilitation technologies such as virtual reality-assisted gait training have been increasingly incorporated into clinical practice. Virtual reality may enhance patient engagement and promote both motor and cognitive recovery by providing interactive environments and increasing task demands.

Backward walking training has also gained attention as an alternative rehabilitation approach. Compared to forward walking, backward walking requires greater postural control and cognitive processing, similar to dual-task training, and may contribute to improvements in balance and gait performance. However, there is limited evidence directly comparing virtual reality-assisted dual-task gait training with backward walking training in patients with stroke.

This study aims to compare the effects of body weight-supported virtual reality-assisted dual-task gait training and body weight-supported forward and backward gait training on functional capacity, gait parameters, cognitive functions, and psychological status in patients with stroke. The findings of this study are expected to contribute to the development of more effective rehabilitation strategies for improving mobility and functional outcomes in stroke rehabilitation.

Being tested
Virtual Reality-Assisted Gait Training, Backward Gait Training, Forward Gait Training
Keywords
stroke, gait training
Medical subject headings
Stroke

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Virtual Reality-Assisted Gait TrainingOther

    Body weight-supported virtual reality-assisted forward gait training with 30% body weight support, applied five days per week for six weeks.

  • Backward Gait TrainingOther

    Body weight-supported backward gait training with 30% body weight support, applied five days per week for six weeks.

  • Forward Gait TrainingOther

    Body weight-supported forward gait training with 30% body weight support, applied five days per week for six weeks.

Study groups in NCT07550270
Study groupRoleWhat they receive
Virtual Reality-Assisted Forward Gait TrainingExperimentalParticipants in this group will receive conventional rehabilitation, including physiotherapy, occupational therapy, and speech, language, and swallowing therapy, for six weeks (five days per week, approximately 2-3 hours per day). In addition, participants will undergo body weight-supported virtual reality-assisted forward gait training with 30% body weight support for six weeks (five days per week, 30 minutes per day).
Receives: Other: Virtual Reality-Assisted Gait Training
Backward Gait TrainingExperimentalParticipants in this group will receive conventional rehabilitation, including physiotherapy, occupational therapy, and speech, language, and swallowing therapy, for six weeks (five days per week, approximately 2-3 hours per day). In addition, participants will undergo body weight-supported backward gait training with 30% body weight support for six weeks (five days per week, 30 minutes per day).
Receives: Other: Backward Gait Training
Forward Gait TrainingExperimentalParticipants in this group will receive conventional rehabilitation, including physiotherapy, occupational therapy, and speech, language, and swallowing therapy, for six weeks (five days per week, approximately 2-3 hours per day). In addition, participants will undergo body weight-supported forward gait training with 30% body weight support for six weeks (five days per week, 30 minutes per day).
Receives: Other: Forward Gait Training

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. 10-Meter Walk Test

    A measure used to assess patients' ambulation. During the test, the patient walks at a comfortable walking speed between two markers placed 10 meters apart, and the time required to complete the distance is recorded.

    Measured: At baseline and after 6 weeks of intervention.

Secondary outcomes (17)
  1. 6-Minute Walk Test (6MWT)

    A submaximal exercise test commonly used to assess functional capacity and response to treatment. During the test, participants are instructed to walk as far as possible within six minutes. The total distance walked is recorded as an indicator of cardiopulmonary capacity and exercise tolerance.

    Measured: At baseline and after 6 weeks of intervention

  2. Fugl-Meyer Assessment - Lower Extremity Motor Subscale

    A standardized assessment used to evaluate sensorimotor impairment in individuals with stroke. The lower extremity motor subscale measures motor recovery and functional movement of the lower limb following stroke.

    Measured: At baseline and after 6 weeks of intervention

  3. Functional Independence Measure (FIM)

    A widely used assessment tool for evaluating functional abilities in individuals undergoing rehabilitation. The scale assesses both motor and cognitive domains, including self-care, sphincter control, transfers, mobility, communication, and social interaction.

    Measured: At baseline and after 6 weeks of intervention.

  4. Berg Balance Scale (BBS)

    A widely used clinical test for assessing static and dynamic balance abilities. The test consists of a series of functional balance tasks, each scored on a scale from 0 (unable) to 4 (independent), with the total score representing overall balance performance.

    Measured: At baseline and after 6 weeks of intervention.

  5. Montreal Cognitive Assessment (MoCA)

    A brief cognitive screening tool used to assess cognitive functions, including memory, attention, language, visuospatial abilities, executive functions, calculation, and orientation. The test is scored on a 30-point scale, with higher scores indicating better cognitive performance.

    Measured: At baseline and after 6 weeks of intervention.

  6. Stroke-Specific Quality of Life Scale (SS-QOL)

    A standardized measure used to assess health-related quality of life in individuals with stroke, covering physical, emotional, and social domains affected by the condition.

    Measured: At baseline and after 6 weeks of intervention.

  7. Hospital Anxiety and Depression Scale (HADS)

    A 14-item self-report questionnaire designed to assess the presence and severity of anxiety and depression symptoms in clinical populations.

    Measured: At baseline and after 6 weeks of intervention.

  8. Foot Rotation

    Gait analysis will be performed using the Zebris RehaWalk® system. Foot rotation (foot progression angle) quantifies the angular deviation of the foot relative to the direction of walking, measured in degrees.

    Measured: At baseline and after 6 weeks of intervention.

  9. Step Width

    Gait analysis will be performed using the Zebris RehaWalk® system. Step width measures the mediolateral distance between the heel centers of consecutive footfalls during walking.

    Measured: At baseline and after 6 weeks of intervention.

  10. Step Length

    Gait analysis will be performed using the Zebris RehaWalk® system. Step length measures the anteroposterior distance between the heel contact point of one foot and the heel contact point of the contralateral foot during walking.

    Measured: At baseline and after 6 weeks of intervention.

  11. Stance Phase

    Gait analysis will be performed using the Zebris RehaWalk® system. Stance phase represents the percentage of the gait cycle during which the foot remains in contact with the ground.

    Measured: At baseline and after 6 weeks of intervention.

  12. Swing Phase

    Gait analysis will be performed using the Zebris RehaWalk® system. Swing phase represents the percentage of the gait cycle during which the foot is off the ground.

    Measured: At baseline and after 6 weeks of intervention.

  13. Double Stance

    Gait analysis will be performed using the Zebris RehaWalk® system. Double stance represents the percentage of the gait cycle during which both feet are simultaneously in contact with the ground.

    Measured: At baseline and after 6 weeks of intervention.

  14. Gait Velocity

    Gait analysis will be performed using the Zebris RehaWalk® system. Gait velocity measures the distance covered per unit time during walking, with reduced speed being one of the most sensitive indicators of hemiparetic gait impairment post-stroke.

    Measured: At baseline and after 6 weeks of intervention.

  15. Cadence

    Gait analysis will be performed using the Zebris RehaWalk® system. Cadence measures the number of steps taken per minute during walking, reflecting the temporal coordination of the gait cycle

    Measured: At baseline and after 6 weeks of intervention.

  16. Maximum Plantar Pressure

    Gait analysis will be performed using the Zebris RehaWalk® system. Maximum plantar pressure measures the peak pressure exerted on the foot sole during the stance phase of gait.

    Measured: At baseline and after 6 weeks of intervention.

  17. Center of Pressure, Lateral Symmetry

    Gait analysis will be performed using the Zebris RehaWalk® system. Center of Pressure (COP) Lateral Symmetry measures the mediolateral displacement of the center of pressure between the paretic and non-paretic limbs during walking, reported in millimeters.

    Measured: At baseline and after 6 weeks of intervention.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted24 Apr 2026
  2. Study start26 Mar 2026
  3. Primary completionNov 2026 (estimated)
  4. Study completionDec 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Investigator, Outcomes assessor
Enrolment
30 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07550270
Sponsor's protocol ID
E2-25-13626
Status last verified
Mar 2026
First submitted
25 Mar 2026
Last updated
24 Apr 2026
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Virtual Reality-Assisted Gait Training, Backward Gait Training and Forward Gait Training in people with Stroke and Walking Impairment, run by Gaziler Physical Medicine and Rehabilitation Education and Research Hospital at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 9 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 24 Apr 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Irem ERTORAN INAN, MD (03122912422, irem.ertoran@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

10-Meter Walk Test (time frame: At baseline and after 6 weeks of intervention.). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 24 Apr 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in
Clinical Trial NCT07550270 | AzTrials